Bessemer Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $590K | Buy |
9,380
+1,218
| +15% | +$84.8K | ﹤0.01% | 1084 |
|
|
2025
Q4 | $542K | Sell |
8,162
-615,708
| -99% | -$39.8M | ﹤0.01% | 1113 |
|
|
2025
Q3 | $42M | Sell |
623,870
-319,073
| -34% | -$25.3M | 0.06% | 195 |
|
|
2025
Q2 | $82.3M | Sell |
942,943
-6,148
| -0.6% | -$482K | 0.13% | 166 |
|
|
2025
Q1 | $64.8M | Buy |
949,091
+25,459
| +3% | +$2.08M | 0.12% | 167 |
|
|
2024
Q4 | $71.8M | Sell |
923,632
-40,276
| -4% | -$2.98M | 0.12% | 162 |
|
|
2024
Q3 | $64.6M | Buy |
963,908
+14,954
| +2% | +$1.23M | 0.11% | 171 |
|
|
2024
Q2 | $108M | Sell |
948,954
-6,207
| -0.6% | -$785K | 0.19% | 132 |
|
|
2024
Q1 | $132M | Sell |
955,161
-372,228
| -28% | -$46.8M | 0.24% | 117 |
|
|
2023
Q4 | $165M | Buy |
1,327,389
+285,136
| +27% | +$29.1M | 0.32% | 88 |
|
|
2023
Q3 | $97.2M | Buy |
1,042,253
+2,160
| +0.2% | +$243K | 0.21% | 131 |
|
|
2023
Q2 | $134M | Buy |
1,040,093
+25,061
| +2% | +$3.03M | 0.28% | 97 |
|
|
2023
Q1 | $118M | Buy |
1,015,032
+9,603
| +1% | +$1.07M | 0.28% | 105 |
|
|
2022
Q4 | $114M | Buy |
1,005,429
+23,173
| +2% | +$2.54M | 0.28% | 115 |
|
|
2022
Q3 | $79.1M | Buy |
982,256
+31,443
| +3% | +$2.66M | 0.21% | 134 |
|
|
2022
Q2 | $70.9M | Sell |
950,813
-203,647
| -18% | -$18.6M | 0.18% | 145 |
|
|
2022
Q1 | $148M | Buy |
1,154,460
+129,120
| +13% | +$14.1M | 0.31% | 100 |
|
|
2021
Q4 | $138M | Buy |
1,025,340
+1,996
| +0.2% | +$287K | 0.28% | 115 |
|
|
2021
Q3 | $140M | Buy |
1,023,344
+436
| +0% | +$55K | 0.3% | 110 |
|
|
2021
Q2 | $109M | Buy |
1,022,908
+93,012
| +10% | +$8.93M | 0.24% | 140 |
|
|
2021
Q1 | $83.5M | Buy |
929,896
+177,000
| +24% | +$16.6M | 0.2% | 148 |
|
|
2020
Q4 | $69.6M | Sell |
752,896
-372
| -0% | -$33.2K | 0.18% | 147 |
|
|
2020
Q3 | $77.6M | Buy |
753,268
+344,472
| +84% | +$36M | 0.23% | 116 |
|
|
2020
Q2 | $41.4M | Buy |
+408,796
| New | +$36.6M | 0.13% | 149 |
|
|
2019
Q2 | – | Sell |
-120
| Closed | -$4K | – | 1677 |
|
|
2019
Q1 | $4K | Sell |
120
-68
| -36% | -$2.39K | ﹤0.01% | 1621 |
|
|
2018
Q4 | $6K | Hold |
188
| – | – | ﹤0.01% | 1737 |
|
|
2018
Q3 | $7K | Buy |
+188
| New | +$5.83K | ﹤0.01% | 1639 |
|
|
2017
Q4 | – | Sell |
-1,060
| Closed | -$13K | – | 1720 |
|
|
2017
Q3 | $13K | Hold |
1,060
| – | – | ﹤0.01% | 1564 |
|
|
2017
Q2 | $19K | Buy |
+1,060
| New | +$19.6K | ﹤0.01% | 1487 |
|
|
2015
Q3 | – | Sell |
-320
| Closed | -$6K | – | 1646 |
|
|
2015
Q2 | $6K | Buy |
+320
| New | +$5.62K | ﹤0.01% | 1320 |
|
Other funds holding DXCM
VCM
VPM
Bessemer Group's DXCM Position: Q1 2026 in Review
Bessemer Group increased its DexCom (DXCM) stake by 15% in Q1 2026, buying an estimated $84.8K and bringing the position to 9,380 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #1084.
Bessemer Group first reported a position in DXCM in Q2 2015 and has held it in 30 quarters since. The position peaked at $165M in Q4 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Bessemer Group held 9,380 shares of DexCom worth $590K as of Q1 2026.
- Bessemer Group bought 1,218 DexCom shares in Q1 2026, an estimated $84.8K.
- DexCom made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #1084 holding.
- Bessemer Group first reported a position in DexCom in Q2 2015 and has held it in 30 quarters since.
- Bessemer Group's DexCom position peaked at $165M in Q4 2023.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.